Table 1. Group Characteristics and Growth According to GC Regimen.
| Characteristic | Median (IQR) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Daily Deflazacort (n = 41) | Intermittent Deflazacort (n = 13) | Daily Prednisolone (n = 152) | Intermittent Prednisolone (n = 131) | GC Naive (n = 44) | ||||||
| Baseline | Last Visit | Baseline | Last Visit | Baseline | Last Visit | Baseline | Last Visit | Baseline | Last Visit | |
| Age, y | 7.4 (5.8 to 10.5) | 10.1 (9.0 to 14.0) | 6.8 (5.4 to 9.0) | 11.4 (9.2 to 13.4) | 7.0 (5.3 to 8.3) | 10.0 (7.8 to 13.0) | 5.6 (6.7 to 10.7) | 10.7 (9.3 to 13.2) | 5.3 (4.0 to 6.5) | 6.8 (4.9 to 8.0) |
| Duration of follow-up, y | 2.5 (1.6 to 5.2) | 4.0 (2.2 to 5.7) | 2.8 (1.5 to 4.6) | 5.1 (2.6 to 5.4) | 1.7 (0.9 to 2.1) | |||||
| Nonambulant, No./total No. (%) | 1/41 (2) | 10/41 (24) | 0/152 (0) | 38/152 (25) | 1/131 (1) | 21/131 (16) | 0/13 (0) | 6/13 (46) | 0/44 (0) | 1/44 (2) |
| SDS | ||||||||||
| Height | −1.4 (−2.9 to −0.6) | −2.6 (−3.2 to −1.6)a | −1.0 (−1.9 to −0.4) | −1.4 (−2.3 to 0.4)a | −1.2 (−1.9 to −0.5) | −1.3 (−2.2 to 0.2) | −0.9 (−1.3 to −0.4) | −1.3 (−1.7 to −0.5) | −0.8 (−1.7 to −0.4) | −0.9 (−1.6 to −0.3) |
| Change in height | −0.6 (−1.5 to −0.1) | −0.4 (−1.1 to 0.3) | 0.0 (−0.5 to 0.3) | −0.4 (−0.8 to −0.1) | −0.1 (−0.4 to 0.4) | |||||
| Body mass indexb | 1.8 (1.2 to 2.9) | 2.3 (0.8 to 3.2) | 1.2 (0.4 to 1.7) | 1.9 (1.0 to 2.6)a | 1.1 (0.3 to 1.8) | 1.7 (0.6 to 2.3)a | 1.7 (0.9 to 2.0) | 1.6 (1.0 to 2.3) | 1.1 (0.3 to 1.5) | 1.0 (−0.5 to 1.5) |
| Change in body mass index | 0.1 (−0.4 to 0.5) | 0.6 (0.0 to 1.3) | 0.3 (−0.2 to 1.0) | 0.1 (−0.1 to 0.3) | 0.0 (−0.3 to 0.3) | |||||
Abbreviations: GC, glucocorticoid; IQR, interquartile range; SDS, standard deviation score.
a
P < .001 (last visit vs baseline).
b
Calculated as weight in kilograms divided by height in meters squared.